{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:23:32Z","timestamp":1791149012964,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1093\/jnci\/dju504","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T04:22:19Z","timestamp":1424319739000},"source":"Crossref","is-referenced-by-count":19,"title":["Combined Treatment Strategies for Microtubule Stabilizing Agent-Resistant Tumors"],"prefix":"10.1093","volume":"107","author":[{"given":"Angela","family":"Broggini-Tenzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna J.","family":"Nytko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Orlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pruschy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,18]]},"reference":[{"issue":"11","key":"key\n\t\t\t\t20170521010406_CIT0001","first-page":"2325","article-title":"Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action","volume":"55","author":"Bollag","year":"1995","journal-title":"Cancer Res"},{"issue":"4","key":"key\n\t\t\t\t20170521010406_CIT0002","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1074\/jbc.272.4.2534","article-title":"Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R))","volume":"272","author":"Kowalski","year":"1997","journal-title":"J Biol Chem"},{"issue":"3","key":"key\n\t\t\t\t20170521010406_CIT0003","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1083\/jcb.94.3.688","article-title":"Taxol binds to cellular microtubules","volume":"94","author":"Manfredi","year":"1982","journal-title":"J Cell Biol"},{"issue":"3","key":"key\n\t\t\t\t20170521010406_CIT0004","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1073\/pnas.77.3.1561","article-title":"Taxol stabilizes microtubules in mouse fibroblast cells","volume":"77","author":"Schiff","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"key\n\t\t\t\t20170521010406_CIT0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3816\/CBC.2000.n.002","article-title":"Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials","volume":"1","author":"Sparano","year":"2000","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"key\n\t\t\t\t20170521010406_CIT0006","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.2000.18.3.623","article-title":"Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial","volume":"18","author":"Bonomi","year":"2000","journal-title":"J Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t20170521010406_CIT0007","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1039\/B515619J","article-title":"Anticancer drugs from nature--natural products as a unique source of new microtubule-stabilizing agents","volume":"24","author":"Altmann","year":"2007","journal-title":"Nat Prod Rep"},{"issue":"1","key":"key\n\t\t\t\t20170521010406_CIT0008","first-page":"3","article-title":"Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines","volume":"1","author":"He","year":"2001","journal-title":"Mol Cancer Ther"},{"key":"key\n\t\t\t\t20170521010406_CIT0009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.biochem.69.1.277","article-title":"Structural insights into microtubule function","volume":"69","author":"Nogales","year":"2000","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"key\n\t\t\t\t20170521010406_CIT0010","first-page":"M79","article-title":"Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity","volume":"1470","author":"Altmann","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"key\n\t\t\t\t20170521010406_CIT0011","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1188\/10.CJON.65-71","article-title":"Ixabepilone","volume":"14","author":"Stein","year":"2010","journal-title":"Clin J Oncol Nurs"},{"issue":"1\u20132","key":"key\n\t\t\t\t20170521010406_CIT0012","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.gene.2007.11.015","article-title":"Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3\u2019 flanking region","volume":"409","author":"Raspaglio","year":"2008","journal-title":"Gene"},{"issue":"3","key":"key\n\t\t\t\t20170521010406_CIT0013","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"key\n\t\t\t\t20170521010406_CIT0014","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1172\/JCI119642","article-title":"Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes","volume":"100","author":"Kavallaris","year":"1997","journal-title":"J Clin Invest"},{"issue":"4","key":"key\n\t\t\t\t20170521010406_CIT0015","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1158\/1078-0432.CCR-08-0969","article-title":"Role of the microenvironment for radiosensitization by patupilone","volume":"15","author":"Bley","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"23","key":"key\n\t\t\t\t20170521010406_CIT0016","first-page":"6938","article-title":"Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs","volume":"62","author":"Bocci","year":"2002","journal-title":"Cancer Res"},{"issue":"21","key":"key\n\t\t\t\t20170521010406_CIT0017","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1158\/1078-0432.CCR-05-1165","article-title":"Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure","volume":"11","author":"Ferretti","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"10","key":"key\n\t\t\t\t20170521010406_CIT0018","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1158\/1535-7163.1301.3.10","article-title":"Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway","volume":"3","author":"Pasquier","year":"2004","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"key\n\t\t\t\t20170521010406_CIT0019","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jss.2009.12.001","article-title":"Metronomic dosing enhances the anti-angiogenic effect of epothilone B","volume":"169","author":"Stalder","year":"2011","journal-title":"J Surg Res"},{"issue":"19","key":"key\n\t\t\t\t20170521010406_CIT0020","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1158\/0008-5472.CAN-04-4095","article-title":"Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function","volume":"65","author":"Escuin","year":"2005","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170521010406_CIT0021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1748-717X-8-105","article-title":"The microtubule stabilizer patupilone counteracts ionizing radiation-induced matrix metalloproteinase activity and tumor cell invasion","volume":"8","author":"Furmanova-Hollenstein","year":"2013","journal-title":"Radiat Oncol"},{"issue":"12","key":"key\n\t\t\t\t20170521010406_CIT0022","doi-asserted-by":"crossref","first-page":"e51476","DOI":"10.1371\/journal.pone.0051476","article-title":"Dynamics of tumor hypoxia in response to patupilone and ionizing radiation","volume":"7","author":"Orlowski","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"key\n\t\t\t\t20170521010406_CIT0023","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.lungcan.2011.01.010","article-title":"Regulation of VEGF-expression by patupilone and ionizing radiation in lung adenocarcinoma cells","volume":"73","author":"Rohrer Bley","year":"2011","journal-title":"Lung Cancer"},{"issue":"7","key":"key\n\t\t\t\t20170521010406_CIT0024","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ejca.2005.12.018","article-title":"Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel","volume":"42","author":"Faried","year":"2006","journal-title":"Eur J Cancer"},{"issue":"3","key":"key\n\t\t\t\t20170521010406_CIT0025","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10549-013-2689-5","article-title":"A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy","volume":"141","author":"Hurvitz","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"20","key":"key\n\t\t\t\t20170521010406_CIT0026","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1158\/1078-0432.CCR-04-0361","article-title":"Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells","volume":"10","author":"Mondesire","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"1","key":"key\n\t\t\t\t20170521010406_CIT0027","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/CAD.0b013e3283400a20","article-title":"Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo","volume":"22","author":"O\u2019Reilly","year":"2011","journal-title":"Anticancer Drugs"},{"issue":"6","key":"key\n\t\t\t\t20170521010406_CIT0028","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/bjc.2013.467","article-title":"A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer","volume":"109","author":"Sun","year":"2013","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20170521010406_CIT0029","doi-asserted-by":"crossref","first-page":"103830","DOI":"10.1155\/2013\/103830","article-title":"Enhanced Antitumor Activity with Combining Effect of mTOR Inhibition and Microtubule Stabilization in Hepatocellular Carcinoma","volume":"2013","author":"Zhou","year":"2013","journal-title":"Int J Hepatol"},{"issue":"26","key":"key\n\t\t\t\t20170521010406_CIT0030","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"key\n\t\t\t\t20170521010406_CIT0031","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1158\/1078-0432.CCR-04-1800","article-title":"Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo","volume":"11","author":"Hofstetter","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"5","key":"key\n\t\t\t\t20170521010406_CIT0032","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1158\/1078-0432.CCR-08-2057","article-title":"mTOR inhibitor RAD001 (everolimus) has antiangiogenic\/vascular properties distinct from a VEGFR tyrosine kinase inhibitor","volume":"15","author":"Lane","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"2","key":"key\n\t\t\t\t20170521010406_CIT0033","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3892\/ijo.2012.1469","article-title":"Differential response to EGFR- and VEGF-targeted therapies in patient-derived tumor tissue xenograft models of colon carcinoma and related metastases","volume":"41","author":"Jin","year":"2012","journal-title":"Int J Oncol"},{"issue":"11","key":"key\n\t\t\t\t20170521010406_CIT0034","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00432-012-1270-7","article-title":"Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts","volume":"138","author":"Zhou","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"issue":"19","key":"key\n\t\t\t\t20170521010406_CIT0035","first-page":"5417","article-title":"Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity","volume":"51","author":"Mickisch","year":"1991","journal-title":"Cancer Res"},{"issue":"8","key":"key\n\t\t\t\t20170521010406_CIT0036","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/S0041-1345(02)03658-8","article-title":"Interaction of immunosuppressive agents rapamycin and its analogue SDZ-RAD with endothelial P-gp","volume":"34","author":"Laplante","year":"2002","journal-title":"Transplant Proc"},{"issue":"1","key":"key\n\t\t\t\t20170521010406_CIT0037","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/1756-0500-6-254","article-title":"Paclitaxel-resistant advanced recurrent breast cancer: a case of partial response because of addition of bevacizumab to paclitaxel therapy: a case report","volume":"6","author":"Ishizuna","year":"2013","journal-title":"BMC Res Notes"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/107\/4\/dju504\/17313997\/dju504.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T12:31:16Z","timestamp":1691325076000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/dju504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,18]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,2,18]]},"published-print":{"date-parts":[[2015,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/dju504","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2,18]]}}}